Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Shape Memory Alloy has over two decades of experience developing and commercializing interventional medical devices for structural heart diseases. It holds a leading position in China with the most comprehensive product portfolio targeting congenital defects, stroke prevention via left atrial appendage closure, and valvular interventions. The company’s innovations include fully biodegradable occluders and advanced nitinol-based implants. Several products are commercially available in China with ongoing R&D into next-generation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Shape Memory Alloy Co., Ltd..